| Prognosis and improved outcomes in major depression: a review C Kraus, B Kadriu, R Lanzenberger, CA Zarate Jr, S Kasper Translational psychiatry 9 (1), 127, 2019 | 477 | 2019 |
| Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice F Matrisciano, P Tueting, I Dalal, B Kadriu, DR Grayson, JM Davis, ... Neuropharmacology 68, 184-194, 2013 | 306 | 2013 |
| Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice RC Agís-Balboa, G Pinna, F Pibiri, B Kadriu, E Costa, A Guidotti Proceedings of the National Academy of Sciences 104 (47), 18736-18741, 2007 | 195 | 2007 |
| Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments B Kadriu, L Musazzi, ID Henter, M Graves, M Popoli, CA Zarate Jr International Journal of Neuropsychopharmacology 22 (2), 119-135, 2019 | 174 | 2019 |
| Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder M Veldic, B Kadriu, E Maloku, RC Agis-Balboa, A Guidotti, JM Davis, ... Schizophrenia research 91 (1-3), 51-61, 2007 | 165 | 2007 |
| An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes A Zhubi, M Veldic, NV Puri, B Kadriu, H Caruncho, I Loza, H Sershen, ... Schizophrenia research 111 (1-3), 115-122, 2009 | 153 | 2009 |
| Ketamine and beyond: investigations into the potential of glutamatergic agents to treat depression MS Lener, B Kadriu, CA Zarate Drugs 77, 381-401, 2017 | 134 | 2017 |
| Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression E Maloku, IR Covelo, I Hanbauer, A Guidotti, B Kadriu, Q Hu, JM Davis, ... Proceedings of the National Academy of Sciences 107 (9), 4407-4411, 2010 | 126 | 2010 |
| Ketamine and serotonergic psychedelics: common mechanisms underlying the effects of rapid-acting antidepressants B Kadriu, M Greenwald, ID Henter, JR Gilbert, C Kraus, LT Park, ... International Journal of Neuropsychopharmacology 24 (1), 8-21, 2021 | 102 | 2021 |
| Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression EE Acevedo-Diaz, GW Cavanaugh, D Greenstein, C Kraus, B Kadriu, ... Journal of affective disorders 263, 568-575, 2020 | 101 | 2020 |
| Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals A Mkrtchian, JW Evans, C Kraus, P Yuan, B Kadriu, AC Nugent, JP Roiser, ... Molecular psychiatry 26 (7), 3292-3301, 2021 | 91 | 2021 |
| Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales ED Ballard, JS Yarrington, CA Farmer, MS Lener, B Kadriu, N Lally, ... Journal of affective disorders 231, 51-57, 2018 | 91 | 2018 |
| A major role for the lateral habenula in depressive illness: physiologic and molecular mechanisms PW Gold, B Kadriu Frontiers in Psychiatry 10, 320, 2019 | 79 | 2019 |
| Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects R Moaddel, M Shardell, M Khadeer, J Lovett, B Kadriu, S Ravichandran, ... Psychopharmacology 235, 3017-3030, 2018 | 78 | 2018 |
| Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression CA Farmer, JR Gilbert, R Moaddel, J George, L Adeojo, J Lovett, ... Neuropsychopharmacology 45 (8), 1398-1404, 2020 | 76 | 2020 |
| The influence of ketamine on drug discovery in depression C Kraus, D Wasserman, ID Henter, E Acevedo-Diaz, B Kadriu, ... Drug Discovery Today 24 (10), 2033-2043, 2019 | 74 | 2019 |
| The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response B Kadriu, CA Farmer, P Yuan, LT Park, ZD Deng, R Moaddel, ID Henter, ... Molecular psychiatry 26 (8), 4085-4095, 2021 | 72 | 2021 |
| Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D) J Rabinowitz, JBW Williams, A Anderson, DJ Fu, N Hefting, B Kadriu, ... Journal of affective disorders 302, 273-279, 2022 | 69 | 2022 |
| Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder B Kadriu, PW Gold, DA Luckenbaugh, MS Lener, ED Ballard, MJ Niciu, ... Molecular psychiatry 23 (7), 1626-1631, 2018 | 65 | 2018 |
| A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression LT Park, B Kadriu, TD Gould, P Zanos, D Greenstein, JW Evans, P Yuan, ... International Journal of Neuropsychopharmacology 23 (7), 417-425, 2020 | 58 | 2020 |
Carlos ZarateNational Institute of Mental HealthVerified email at mail.nih.gov
